Home >

The First Batch Of Two Annual Reports Of The Gem Has Been Released &Nbsp, And The Organization'S Anticipation Has Been Preemptive.

2011/1/28 10:08:00 48

??? 日本語 Fran?ais English 中文

Xinghe Biology (300143, stock bar), Shuanglong stock (300108, stock bar) annual report released today, opened the gem annual report disclosure curtain.

Two families

During the reporting period, the growth of performance was achieved, but the difference was quite wide. But both companies drew the eye of many institutional investors at the end of December.

Xinghe also issued a high profit distribution plan.

The annual report of Xinghe biology listed in December 9th last year showed that the company achieved operating income of 168 million yuan in 2010 and a net profit of 42 million 200 thousand yuan, up 75.35% and 107.39% respectively from the same period last year, and the basic earnings per share were 0.82 yuan.

Xinghe biology is mainly engaged in edible fungus industry. The main products include three kinds of fresh food, Flammulina velutipes, mushroom and white mushroom.

Use of bacteria

During the reporting period, due to the expansion of production scale, the three realized business income of 118 million yuan, 39 million yuan and 10 million 300 thousand yuan respectively, representing an increase of 77%, 56% and 210% respectively, with gross margins of 40.07%, 53.82% and 55.51% respectively. The gross profit margin of the other two products increased sharply except for the slight decline in the gross margin of Flammulina velutipes.

In 2010, the actual output of the company's edible fungus was 14198 tons, while the company plans to increase the total annual output of the edible fungus in 2011 to about 18720 tons in 2011.

At the same time, as the market competition of Flammulina velutipes is fierce and the gross profit margin level is declining, the company intends to adjust the annual proportion of the three products from the current 82%, 15% and 3% to 70%, 20% and 10% in the next three years, so as to improve the overall profitability.

The company said that in order to meet the needs of expansion, the company did not allocate dividends at any time. The annual allocation plan was based on the total share capital of 67 million shares and the 12 shares of every 10 shares of the capital reserve.

Increase by pferring

The total share capital of the 80 million 400 thousand shares of the company is 147 million 400 thousand shares.

The expectation of "high delivery and pfer" and the "consumption concept" have attracted many institutions to enter.

The annual report shows that less than January, as of the end of December, 7 institutions, including financial products, social security funds and public offering funds, have become the top ten tradable shareholders of the company. They hold 2 million 500 thousand shares. Among them, Yinhua is rich (180012, fund bar) is the largest shareholder in circulation with 1 million shares, and there are 3 gold funds on the list of the Societe Generale fund, with 1 million 100 thousand shares in total.

Shuanglong shares reached 2010 yuan in the whole year, operating income of 113 million yuan, an increase of 43.38% over the same period. The net profit attributable to shareholders of the company was 24 million 380 thousand yuan, an increase of 3.71% over the previous year, and the basic earnings per share were 0.56 yuan.

The company's profit distribution plan is based on the total share capital of 52 million shares, and the cash dividends are distributed 1.2 yuan (including tax) for every 10 shares, while the 3 shares of every 10 shares of the capital reserve fund are converted into 15 million 600 thousand shares.

Compared with the end of the three quarter, many of the top ten tradable shareholders were stationed in the company.

5 funds, including GF industry and China's steady growth (519029, fund bar), have become the top ten tradable shareholders, with a total holding volume of 1 million 950 thousand shares.